Neuropathology

Isidre Ferrer Abizanda

PRINCIPAL INVESTIGATORS
  • Franc Llorens Torres
  • Marta Barrachina Castillo
POSTDOCTORAL RESEARCHERS (R2)
  • Paula Garcia Esparcia
PREDOCTORAL RESEARCHERS (R1)
  • Soledad Alcántara Horrillo
  • Cristian Sebastian Melia Gorrias
  • Pol Andres Benito
  • Jose Pablo Soriano Esque
  • Rafel Balada Caballé
  • Alba Aina Castells Santamaria
SCIENTIFIC SUPPORT
  • Margarita Carmona Murillo
  • Daniela Diaz Lucena
Neuroscience
Neuroscience

Scientific production

39

PAPERS

7 PUBLICATIONS IN FIRST DECILE

29 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Blennow K., Diaz-Lucena D., Zetterberg H., Villar-Pique A., Karch A., Vidal E., Hermann P., Schmitz M., Ferrer Abizanda I., Zerr I., Llorens F.. CSF neurogranin as a neuronal damage marker in CJD: A comparative study with AD. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 10.1136/jnnp-2018-320155
  • Llorens, F; Villar-Pique, A; Schmitz, M; Diaz-Lucena, D; Wohlhage, M; Hermann, P; Goebel, S; Schmidt, I; Glatzel, M; Hauw, JJ; Sikorska, B; Liberski, PP; Riggert, J; Ferrer, I; Zerr, I. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 10.1111/nan.12573
  • Aso E, Martinsson I, Appelhans D, Effenberg C, Benseny-Cases N, Cladera J, Gouras G, Ferrer I, Klementieva O . Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection.. NANOMEDICINE: NANOTECHNOLOGY, BIOLOGY, AND MEDICINE. 10.1016/j.nano.2019.01.010
  • Villar-Piqué A, Schmitz M, Lachmann I, Karch A, Calero O, Stehmann C, Sarros S, Ladogana A, Poleggi A, Santana I, Ferrer I, Mitrova E, Žáková D, Pocchiari M, Baldeiras I, Calero M, Collins SJ, Geschwind MD, Sánchez-Valle R, Zerr I, Llorens F . Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.. MOLECULAR NEUROBIOLOGY. 10.1007/s12035-018-1251-1
  • Aso E, Fernández-Dueñas V, López-Cano M, Taura J, Watanabe M, Ferrer I, Luján R, Ciruela F . Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment.. MOLECULAR NEUROBIOLOGY. 10.1007/s12035-018-1456-3

Research highlights

PROJECTS

6 Ongoing projects

1 Started projects

PUBLISHED WORKS

1 Thesis

INNOVATION

1 Patent

1 license

1 spin-off 

Selected projects

  • Modulation of Tau seeding and pathology in tauopathies by BBB-nanocarriers, epitope selective vaccination and ectoPrP Tau receptor bodies (15/9/2019 – 14/12/2022) PI: FERRER ABIZANDA, ISIDRE. Funder: Fundació “La Caixa”.
  • ARTAG (Aging-related tau astrogliopathy) (1/1/2018 – 31/12/2020) PI: FERRER ABIZANDA, ISIDRE. Funder: FIS-Instituto de Salud Carlos III.
  • CONTRATOS I-PFIS: DOCTORADOS IIS-EMPRESA EN CIENCIAS Y TECNOLOGIAS DE LA SALUD (1/1/2016 – 31/12/2019) PI: FERRER ABIZANDA, ISIDRE. Funder: FIS-Instituto de Salud Carlos III.
  • TERAPIA DEL ESPEJO “THE MIRROR THERAPY” ADAPTADA A LA PARÁLISIS FACIAL PERIFÉRICA MEDIANTE LA UTILIZACIÓN DE UN SOPORTE SOFTWARE DE TRATAMIENTO DE IMÁGENES: ESTUDIO EXPERIMENTAL, RANDOMIZADO POR ESTRATOS. (25/1/2017 – 24/1/2019) PI: MONTESINOS MONTESINO, NURIA. Funder: COL.LEGI FISIOTERAPEUTES CATALUNYA.
  • A precise approach for nucleoside-based therapy of neuromuscular disorders with defects in mitochondrial DNA. (1/1/2016 – 31/12/2019) PI: OLIVE PLANA, MONTSERRAT. Funder: FIBHU DOCE DE OCTUBRE (FUND. I+12).